ArticleFrontiers in pharmacology2026
Risk of hyperprolactinemia and extrapyramidal symptoms in antipsychotic-treated schizophrenia: a retrospective single-center real-world study.
Yong Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.